TWO SIGMA ADVISERS, LP - FREELINE THERAPEUTICS HLDGS ownership

Back to all holdings Add to watchlist

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.

Links
Filings
External links
Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2022$11,000
-59.3%
12,200
-49.0%
0.00%–
Q1 2022$27,000–23,900–0.00%–
 Download
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,508$3,783,5915.70%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders